Capnography Devices Market Size & Share 2025 - 2034

Capnography Devices Market Size

The global capnography devices market size was valued at USD 712.6 million in 2024. The market is expected to reach from USD 764.1 million in 2025 to USD 1.2 billion in 2034, growing at a CAGR of 5.4% during the forecast period. The high market growth is attributed to the increasing prevalence of respiratory disease, growing use in emergency and critical care, and rising emphasis on minimally invasive procedures, among other contributing factors.

The respiratory market is growing owing to the increase in people having respiratory problems such as COPD and asthma. According to the World Health Organization (WHO), COPD affected 384 million people globally in 2022, while asthma impacted approximately 339 million individuals. These chronic diseases require advanced preventative measures to avoid complications. Capnography devices provide patients the assurance of safety as they offer real-time insights into the patient’s breath and aid safe surgical and critical care procedures.
 

In addition, these devices are in high demand because of the increased adoption of global minimally invasive surgeries. Capnography devices are necessary for anesthesia supervision, providing advanced safety features to modern healthcare such as hospitals and ambulatory surgical centers.
 

Further, the growth of the market is driven by government regulations that require the use of capnography devices during sedation. The sedation of patients has a rapidly emerging technology healthcare industry, which, in turn, increases the devices safety. Moreover, the availability of portable capnography devices has widened their use in outpatient clinics, emergency medicine, as well as in other non-hospital environments. Also, the rising expenditures for healthcare in developing countries makes these countries attractive for market growth.
 

Capnography devices are advanced medical systems designed for diligently keeping into account the concentration of carbon dioxide (CO₂) in a patient’s exhaled breath. The healthcare personnel can now act preemptively in order to avoid any issues arising in the future with the availability of real-time respiratory data provided by the device.These instruments are critical in monitoring ventilation and safeguarding the patient’s well-being during anesthesia, sedation, and during the recovery phase in critical care.
 

Capnography Devices Market Trends

The market for capnography devices is being shaped by a number of trends. The emergence of portable and handheld devices has greatly increased their use in hospitals, outpatient clinics, and home healthcare settings. Their active monitoring can be carried out in unconventional settings which encourages the acceptance by health providers.
 

• Accurate monitoring is provided for the neonatal and pediatric population through microstream and other similar technologies that fill the gaps in pediatric and neonatal care.  In addition, the integration of capnography monitors into electronic health record (EHR) systems is optimizing data management for patients, thereby increasing the operational efficacy of healthcare facilities. These instruments are critical in monitoring ventilation and safeguarding the patient’s well-being during anesthesia, sedation, and during the recovery phase in critical care.
   
• Further, the growing understanding of capnography’s usefulness in procedural sedation and critical care is further driving its adoption among healthcare practitioners. CO₂ monitoring training programs and workshops are actively teaching practitioners as well, which improves patient safety, contributing to the growing market demand.
   

Trump Administration Tariffs

• The trump’s reciprocal tariffs will negatively impact multiple industries, including the medical devices industry, due to restrictions on capnography devices. Capnography, which refers to the measurement of race carbon dioxide in the breath of a patient, had its tariffs affecting components such as sensors and electronic circuits, which were parts of capnography system systems.
   
• These tariffs will hurt the majority of U.S. based manufacturers and distributors of capnography devices, given that a large proportion of them relied on Chinese suppliers for cost-effective key components and more advanced products. The increased spending for critical components along with guaranteed cost increases fees disrupted numerous supply chains. Some manufacturers may opt to offload the cost to the end-users such as the hospitals and clinics, whom which the devices will be supplied to, which is expected to boost the cost of healthcare. Alternatively, manufacturers may try to seek suppliers for these parts outside China, but shifting production will be time-consuming especially in the tightly regulated medical appliances sector.
   
• Moreover, the lack of clarity regarding the timeline and range of the tariffs may also delay in medical device capital investment activities and firm-level strategic foresight. Inclusion of tariffs would adversely affect patient care and public health. For firms active in the market, this lack of clear regulation may also complicate the planning of procurement and pricing approaches and as a result, stifled competition, innovation, and throttle supply chains in the market.
   
• Overall, the Trump’s reciprocoal tarrifs will place an unforeseen costs as well as operational burdens on the market while simultaneously shatter the established supply chains and elevating financial stress throughout the healthcare system.
   

Capnography Devices Market Analysis

Based on product, the market is segmented as hand-held, stand-alone, and multi-parameter. The hand-held segment is expected to drive business growth and expand at a CAGR of 5%, reaching over USD 603.1 million by 2034.
 

• Handheld capnography devices dominate the market due to their portability and ease of use.  They are idle in pre-hospital and ambulatory care settings. due to their lightweight configuration. Further,  these devices offer real-time monitoring, enabling healthcare providers to make informed decisions during critical scenarios, such as procedural sedation and respiratory distress.
   
• These instruments are critical in monitoring ventilation and safeguarding the patient’s well-being during anesthesia, sedation, and during the recovery phase in critical care.
   
• Moreover, healthcare facilities that work under a budget will appreciate the cost-effectiveness of handheld capnography devices over multi-parameter systems. The adaptability to already existing workflows makes wide adoption possible across diverse outpatient and homecare settings. These advantages are expected to drive growth in this segment of the market.
   

Based on technology, the capnography devices market is segmented as side stream, main stream, and micro stream. The side stream segment is expected to drive business growth and expand at a CAGR of 5.1%, reaching over USD 575.8 million by 2034.
 

• The sidestream capnography segment is leading the market due to its flexibility and compatibility with both intubated and non-intubated patients. Sidestream technology works with a CO₂ measuring sampling line and is therefore useful in ICUs, operating rooms and emergency care units.
   
• Owing to its complex nature, this technology ensures virtually universal applicability, particularly in intricate clinical situations that require detailed assessment of ventilatory mechanics. These devices are indispensable for the adequate control of ventilation and preservation of the patient's safety during anesthesia, sedation, and recovery in critical care nursing.
   
• Additionally, sidestream systems are less expensive and easier to maintain than other types of capnography. Their accuracy in low-flow conditions makes them particularly important in pediatric and neonatal care. All these factors make contributing to its market dominance.
   

Based on component, the capnography devices market is segmented as original equipment manufacturer (OEM) modules and other components. The original equipment manufacturer (OEM) modules segment is expected to drive business growth and expand at a CAGR of 5.1%, reaching over USD 530 million by 2034.
 

• The OEM modules have significant market penetration because capnography features are easily incorporated into multi-parameter monitoring systems using OEM modules. For healthcare providers, these modules represent a low-cost option that expands the provider's monitoring capabilities without auxiliary devices. This flexibility is important for diagnostic-system-centric hospitals and manufacturers trying to maximize their resources.
   
• Moreover, the OEM modules compact design enhances their compatibility with other platforms, which broadens their adoption in healthcare facilities. In addition, the rising need for interoperable tailored systems, along with the increasing focus on patient-centered care, makes OEM modules critical in the market. These instruments are critical in monitoring ventilation and safeguarding the patient’s well-being during anesthesia, sedation, and during the recovery phase in critical care, thereby leading to the segmental growth of the market.
   

Based on application, the capnography devices market is segmented as procedural sedation, emergency medicine, critical care, pain management, and other applications. The procedural sedation segment is expected to drive business growth and expand at a CAGR of 5.5%, reaching over USD 366.2 million by 2034.
 

• Respiratory devices monitoring CO₂ levels are a critical component of the market since patient safety is paramount during procedural sedation. These instruments are critical in monitoring ventilation and safeguarding the patient’s well-being during anesthesia, sedation, and during the recovery phase in critical care.
   
• Capnography devices serve to actively monitor a patient’s ventilation so complications such as hypoventilation do not pose a risk during outpatient surgeries like dental work and endoscopies. The integration of capnography devices into procedural sedation practices has improved surgical patient outcomes.
   
• Moreover, the adoption of capnography devices has grown rapidly in this application segment due to the increased global demand for capnography in procedural sedation, alongside regulations requiring respiratory monitoring during sedation.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on end use, the capnography devices market is classified into hospitals, ambulatory surgical centers, and other end users. The hospitals segment dominated the market with a revenue share of 54.7% in 2024.
 

• The hospitals segment captures the larger share of revenue in the market due to the high patient volume and the demand for sophisticated respiratory monitoring systems. These instruments are critical in monitoring ventilation and safeguarding the patient’s well-being during anesthesia, sedation, and during the recovery phase in critical care.
   
• Capnography devices are utilized in the monitoring of ventilation status, patient safety, and risk management across critical care units, surgical theatres, emergency departments, as well as in neonatal intensive care units.
   
• In addition, hospitals have greater spending capability and better capital available for sophisticated capnography systems that are integrated with other monitoring systems. Furthermore, regulatory requirements focus on patient safety during sedation and surgery; therefore, capnography is increasingly being accepted as a standard component in monitoring systems.
   

U.S. capnography devices market accounted for USD 328.3 million in 2024. The U.S. dominated the global market in 2023 with USD 307.5 million growing from USD 287.4 million in 2022 and is anticipated to grow at a CAGR of 4.7% between 2025 to 2034 period.
 

• Capnography equipment is frequently utilized in emergency rooms and hospitals in the U.S. The emphasis on patient safety, the use of monitoring systems during critical care and surgical procedures, and FDA and American Society of Anesthesiologists regulations requiring the use of capnography during anesthesia and procedural sedation are what drive their market adoption and expansion.
   
• These instruments are critical in monitoring ventilation and safeguarding the patient’s well-being during anesthesia, sedation, and during the recovery phase in critical care.
   
• In addition, the surgically directed outpatient procedures being performed in the country are on the rise, leading to an increased adoption of capnography devices.
   
• Furthermore, portable capnography for pre-hospital care in emergency medical services and the monitoring of respiratory function by healthcare providers during non-clinical hours has led to increasing adoption, leading to the country’s growth in the market.
   

U.K. capnography devices market in the Europe is projected to grow remarkably in the coming years.
 

• The use of capnography devices in the UK is on the rise owing to an increased focus on patient safety and overall clinical outcomes. These devices are essential for proper ventilation monitoring and patient stability in critical care environments during anesthesia, sedation, and post-operative recovery. Their application is expanding across all surgical wards, intensive care units, and emergency departments.
   
• The National Health Service (NHS) has actively advocated for the integrated application of capnography in monitoring ventilation to reduce the risks of complications like apnea during surgical and critical care procedures.
   
• Furthermore, the UK has experienced a greater demand for real-time tracking of respiratory metrics due to the intensified burden of chronic respiratory conditions like COPD. As noted by the British Lung Foundation, COPD was estimated to affect 1.2 million individuals in the UK in 2022, making it the second most prevalent lung condition after asthma.
   
• Similarly, the National Health Service (NHS) England stated that respiratory disorders are the basis for more than 700,000 hospital admissions every year. Due to enhanced focus on patient safety, the healthcare industry has experienced wider utilization of capnography devices, especially since the NHS now requires capnography monitoring during sedation and mechanical ventilation procedures.
   

China holds a dominant position in the Asia Pacific capnography devices market.
 

• China’s capnography equipment adoption is supported by the expansion of the country’s health economic growth, the National Health Commission reporting health spending of USD 1.24 trillion in 2021, and country’s increasing elderly population.
   
• The country's growing population of 1.4 billion, as well as the rising prevalence of respiratory disorders, resulting in 113.9 million reported cases by the National Bureau of Statistics in 2022, increasingly drives demand for monitoring systems in hospitals and clinics.
   
• The increasing number of surgical procedures, especially in urban parts of China, is likely to fuel the demand for capnography devices further. These instruments are critical in monitoring ventilation and safeguarding the patient’s well-being during anesthesia, sedation, and during the recovery phase in critical care, making sure the respiration is safely managed.
   

The Brazil capnography devices market is experiencing robust growth in Latin America market.
 

• The growing prevalence of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD) in Brazil, has created a need for efficient monitoring of the patient's respiratory system. For example, the Ministry of Health of Brazil estimates that around 20 million people in Brazil have some form of respiratory disease, with 12% of adults over 40 being afflicted with COPD.
   
• Similarly, the Brazilian Thoracic Society reported a 36% increase in prevalence of asthma from 2018 to 2022. With these conditions, capnography allows monitoring of ventilation in a non-invasive real-time manner and enable enhanced safety for patients enduring anesthesia, sedation, and recovery in critical care units.
   
• In addition, the professional medical societies in Brazil are now advocating for the routine use of capnography during sedation and anesthesia. Such advocacy accelerates the integration of capnography devices into healthcare facilities, contributing to the market growth.
   

Capnography Devices Market Share

The top 5 companies in the capnography devices, such as Medtronic, Masimo Corporation, Philips, Smiths Medical and Dragerwerk , account for approximately 65% of the market share. Key players in the market are focused on product innovation and strategic partnerships to strengthen their market positions. For instance, Medtronic has introduced advanced sidestream capnography systems with improved accuracy. Similarly, partnerships between OEM module providers and healthcare organizations are fostering the seamless integration of capnography into multi-parameter monitors.
 

Capnography Devices Market Companies

Prominent players operating in the capnography devices industry include:

• Becton, Dickinson and Company
• Criticare Systems
• Dragerwerk
• Edan Instruments
• Infinium Medical
• Masimo Corporation
• Medtronic
• Mindray Medical
• Nihon Kohden
• Nonin Medical
• Phillips Healthcare
• Shenzhen Comen Medical Instruments
• Smiths Medical
• ZOLL Medical
   
• Medtronic's Smart Capnography suite, featuring innovations like the Smart Alarm for Respiratory Analysis (SARA) and Integrated Pulmonary Index™ (IPI), minimizes false alarms and enhances respiratory assessments.
   
• Masimo Coproation provides innovative solutions in the market. Masimo's capnography solutions integrate seamlessly with their pulse oximetry technologies, providing comprehensive patient monitoring.
   
• Dragerwerk capnography devices, integral to their comprehensive monitoring systems, oversee multiple vital signs to guarantee patient safety.
   

Capnography Devices Industry News:

• In June 2022, GE Healthcare and Medtronic received FDA 510(k) clearance and CE Mark approval for integrating INVOS regional oximetry and Microstream capnography into the CARESCAPE monitoring platform. This enhanced clinical decision-making and patient safety, boosting the companie’s market competitiveness in advanced monitoring solutions.
   
• In April 2021, Masimo received FDA 510(k) clearance for its Radius PCG, a portable, wireless real-time capnograph that seamlessly integrates with the Root Patient Monitoring Platform. This device provides accurate end-tidal carbon dioxide (EtCO2) and respiration rate measurements within 15 seconds, offering continuous monitoring in a compact, handheld form.
   

The capnography devices market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Hand-held
• Stand-alone
• Multi-parameter

Market, By Technology

• Side stream
• Main stream
• Micro stream

Market, By Component

• Original equipment manufacturer (OEM) modules
• Other components

Market, By Application

• Procedural sedation
• Emergency medicine
• Critical care
• Pain management
• Other applications

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE